Iqvia Holdings (IQV) Net Income towards Common Stockholders (2012 - 2026)
Iqvia Holdings (IQV) posted Net Income towards Common Stockholders of $241.0 million for Q2 2026, down 10.41% sequentially from $269.0 million in Q1 2026, and down 9.74% YoY from $267.0 million in Q2 2025.
Iqvia Holdings (IQV) Net Income towards Common Stockholders (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported Net Income towards Common Stockholders for 15 years, with the latest figure at $241.0 million in Q2 2026.
- Quarterly Net Income towards Common Stockholders fell 9.74% year-over-year to $241.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 billion (up 6.02% YoY) and the FY2025 annual result came in at $1.3 billion, down 2.12% from the prior year.
- Net Income towards Common Stockholders eased to $241.0 million in Q2 2026 per IQV's latest filing, from $269.0 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $478.0 million in Q4 2025 and troughed at $227.0 million in Q4 2022.
- A 5-year average of $315.4 million and a median of $291.0 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders dropped 28.39% in 2022, then soared 109.25% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at $227.0 million in 2022, then jumped by 109.25% to $475.0 million in 2023, then slipped by 9.05% to $432.0 million in 2024, then increased by 10.65% to $478.0 million in 2025, then plunged by 49.58% to $241.0 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $241.0 million, $269.0 million, and $478.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 324.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 241.00 Mn |
| Mar 31, 2026 | 269.00 Mn |
| Dec 31, 2025 | 478.00 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 267.00 Mn |
| Mar 31, 2025 | 262.00 Mn |
| Dec 31, 2024 | 432.00 Mn |
| Sep 30, 2024 | 284.00 Mn |
| Jun 30, 2024 | 361.00 Mn |
| Mar 31, 2024 | 291.00 Mn |
| Dec 31, 2023 | 475.00 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 294.00 Mn |
| Mar 31, 2023 | 291.00 Mn |
| Dec 31, 2022 | 227.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | 329.00 Mn |
| Dec 31, 2021 | 317.00 Mn |
| Sep 30, 2021 | 261.00 Mn |